Skip to main content
. 2013 Aug;5(4):400–405. doi: 10.3978/j.issn.2072-1439.2013.07.28

Figure 1.

Figure 1

Chest CT scan of a patient who had a PR with retreatment of erlotinib. A. Chest CT scan before treatment with erlotinib; B. Chest CT scan 2 months after treatment with erlotinib; C. Chest CT scan before retreatment with erlotinib; D. Chest CT scan after retreatment with 2 months of erlotinib.